Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ruzasvir (MK-8408) is a novel and potent pan-genotypic inhibitor of hepatitis C virus NS5A with antiviral activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 191.00 | |
5 mg | In stock | $ 480.00 | |
10 mg | In stock | $ 687.00 | |
25 mg | In stock | $ 1,080.00 | |
50 mg | In stock | $ 1,480.00 |
Description | Ruzasvir (MK-8408) is a novel and potent pan-genotypic inhibitor of hepatitis C virus NS5A with antiviral activity. |
In vitro | Ruzasvir (MK-8408) was developed as a novel NS5A inhibitor to improve upon the potency and barrier to resistance of early compounds. Ruzasvir inhibited HCV RNA replication with 50% effective concentrations (EC50s) of 1 to 4 pM in Huh7 or Huh7.5 cells bearing replicons for HCV genotype 1 (GT1) to GT7. The antiviral activity was modestly (10-fold) reduced in the presence of 40% normal human serum. The interaction of Ruzasvir with an NS3/4A protease inhibitor (grazoprevir) and an NS5B polymerase prodrug (uprifosbuvir) was additive to synergistic, with no evidence of antagonism or cytotoxicity.[1] |
Synonyms | MK8408, MK-8408, MK 8408 |
Molecular Weight | 947.09 |
Formula | C49H55FN10O7S |
CAS No. | 1613081-64-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ruzasvir 1613081-64-3 Microbiology/Virology Proteases/Proteasome HCV Protease MK8408 MK-8408 MK 8408 inhibitor inhibit